Ignite Creation Date:
2024-05-06 @ 7:47 AM
Last Modification Date:
2024-10-26 @ 11:52 AM
Study NCT ID:
NCT02603315
Status:
COMPLETED
Last Update Posted:
2016-06-01
First Post:
2015-10-28
Brief Title:
Vascularity Impact on the Treatment Outcome in Malignant Pleural MesotheliomaVITMPM
Sponsor:
Ain Shams University
Organization:
Ain Shams University
Study Overview
Official Title:
To Assess the Correlation Between the Predictive Factor of Vascularity CD74 in Malignant Pleural Mesothelioma and Treatment Results Response Rate and Overall Survival
Status:
COMPLETED
Status Verified Date:
2015-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
VITMPM
Brief Summary:
The purpose of this study is to To assess the correlation between the predictive factor of vascularity CD74 in malignant pleural mesothelioma and treatment results response rate and overall survival
Detailed Description:
This is a randomized controlled retrospective study through Examination of paraffin blocks of the patient selected to be included in the study for assessment of the selected vascularity marker of malignant pleural mesothelioma of both types The CD74 LN2 antibody is intended for qualified laboratories to qualitatively identify by light microscopy the presence of associated antigens in sections of formalin-fixed paraffin-embedded tissue sections using Immunohistochemistry test methods
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None